Study Confirms Safety and Effectiveness of Telehealth Medication Abortions

A comprehensive study reveals that telehealth medication abortions are nearly as successful and safe as in-person procedures, ahead of a pivotal Supreme Court case.

A new study confirms that medication abortion via telehealth is as safe and effective as in-person visits, with a success rate of about 98% and a safety rate of 99.8%.
The study, involving over 6,000 cases, is the largest of its kind and comes ahead of a Supreme Court case that could impact access to mifepristone, a key abortion pill.
Researchers found no significant difference in outcomes between telehealth abortions conducted via video calls or secure text messaging.
The FDA's 2021 decision to allow mifepristone to be prescribed via telehealth, based on self-reported medical history, is supported by the study's findings.
The study's results are cited in an amicus brief submitted to the Supreme Court, emphasizing the safety and effectiveness of telehealth medication abortions.